WORCESTER, MA -- (MARKET WIRE) -- April 26, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has entered into an exclusive Product Licensing & Distribution Agreement with Leosons General Trading Company, a leading distributor of North American products in the Middle East, for the distribution of the Company's proprietary Glucose RapidSpray™ product in 15 Middle Eastern countries, including Saudi Arabia and the United Arab Emirates (UAE).
